Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets

Daley S. Morera, Martin Hennig, Asif Talukder, +14

British Journal of Cancer

Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA

Daley S. Morera, Sarrah L. Hasanali, Daniel Belew, +10

The Journal of Urology

A chemokine/chemokine receptor signature potentially predicts clinical outcome in colorectal cancer patients

Andrew Mitchell, Sarrah L. Hasanali, Daley S. Morera, +13

Cancer Biomarkers

β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer

Georgios Kallifatidis, Diandra K. Smith, Daley S. Morera, +10

Molecular Cancer Therapeutics

<i>RAD51AP1</i> Deficiency Reduces Tumor Growth by Targeting Stem Cell Self-Renewal

Allison Bridges, Sabarish Ramachandran, Rajneesh Pathania, +13

Cancer Research

Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma

Jiaojiao Wang, Andre R. Jordan, Huabin Zhu, +15

Cancer Cell International

RAD51AP1 Loss Attenuates Colorectal Cancer Stem Cell Renewal and Sensitizes to Chemotherapy

Allison Bridges, Sabarish Ramachandran, Kavin Tamizhmani, +17

Molecular Cancer Research

A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer

Vinata B. Lokeshwar, Daley S. Morera, Sarrah L. Hasanali, +19

Clinical Cancer Research

Promotion of epithelial hyperplasia by interleukin‐8—CXCR axis in human prostate

Diandra K. Smith, Sarrah L. Hasanali, Jiaojiao Wang, +8

The Prostate

HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder Cancer

Sarrah L. Hasanali, Daley S. Morera, Ronny R. Racine, +15

Clinical Cancer Research